Rebamipide promotes lacrimal duct epithelial cell survival via protecting barrier function

Nasolacrimal duct obstruction (NLDO) is thought to be due to inflammation and fibrosis of lacrimal duct epithelial cells (LDECs). Here we investigated the effect of rebamipide, a drug that is used for the protection of the mucosa and the treatment of gastritis and gastroduodenal ulcers, on LDECs, bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Hiroshi, Nakayama, Tomomichi, Tsukamoto, Michiko, Watanabe, Akihide, Nakamura, Takahiro, Yokoi, Norihiko, Sotozono, Chie, Kinoshita, Shigeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997454/
https://www.ncbi.nlm.nih.gov/pubmed/32015381
http://dx.doi.org/10.1038/s41598-020-58314-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997454/
https://www.ncbi.nlm.nih.gov/pubmed/32015381
http://dx.doi.org/10.1038/s41598-020-58314-x

Ejemplares similares